Logo Logo

Publications by Witzens-Harig, M.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 2.

Journal article

Davies, A.; Trask, P.; Demeter, J.; Florschütz, A.; Hänel, M.; Hong, X.; Kinoshita, T.; Pettengell, R.; Quach, H.; Robinson, S.; Sadullah, S.; Sancho, J.-M.; Udvardy, M.; Witzens-Harig, M.; Rufibach, K.; Zeuner, H.; Unterhalt, M. (2017): Health-Related Quality Of Life Results From The Phase III Gallium Study Of Obinutuzumab-Based And Rituximab-Based Therapy In Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma. In: Haematologica, Vol. 102: pp. 190-191

Witzens-Harig, M.; Keller, U.; Viardot, A.; Buske, C.; Hönig, E.; Crombe, A.; Brandt, J.; Meissner, J.; Ho, A.; La Rosee, P.; Marks, R.; Dreyling, M.; Hess, G. (2016): Safety and clinical activity of temsirolimus in combination with Rituximab and DHAP in patients with relapsed or refractory diffuse large B-cell lymphoma - preliminary results of the storm trial. In: Haematologica, Vol. 101: p. 390

This list was generated on Tue Jun 25 05:01:01 2019 CEST.